Article Details

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II ...

Retrieved on: 2024-06-18 12:06:32

Tags for this article:

Click the tags to see associated articles and topics

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II .... View article details on hiswai:

Excerpt

The CS-AKI Phase II trial is an international multi-center, randomized, double-blind, placebo-controlled study of LSALT peptide with a recruitment ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up